Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24395789.
- Also identified by DOI 10.1073/pnas.1318124111 and PMC identifier 3903200.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pituitary tumor transforming gene 1 (Pttg1) encodes the mammalian securin, which is an inhibitor of separase (a protease required for the separation of sister chromatids in mitosis and meiosis). PTTG1 is overexpressed in a number of human cancers and has been suggested to be an oncogene. However, we found that, in Pttg1-mutant females, the mammary epithelial cells showed increased proliferation and precocious branching morphogenesis. In accord with these phenotypic changes, progesterone receptor, cyclin D1, and Mmp2 were up-regulated whereas p21 (Cdkn1a) was down-regulated. These molecular changes provide explanation for the observed developmental defects, and suggest that Pttg1 is a tumor suppressor. Indeed, mice lacking Pttg1 developed spontaneous mammary tumors. Furthermore, in human breast tumors, PTTG1 protein levels were down-regulated and the reduction was significantly correlated with the tumor grade.
Medical subject headings
- Gene Expression Regulation, Developmental
- Gene Expression Regulation, Neoplastic
- Mammary Glands, Animal
- Mammary Neoplasms, Animal
- Securin